药物设计与发现快报 SCISCIE

期刊简介预计审稿时间：约3.0个月

Aims & Scope

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

目标和范围

Letters in Drug Design & Discovery 在合理药物设计和发现的所有领域（包括药物化学、计算机模拟药物设计、组合化学、高通量筛选、药物目标和结构-活性关系。重点是通过充分利用最新的互联网技术来提交和审阅稿件，从而非常迅速地发表高质量的论文。该在线期刊是所有参与药物设计和发现研究的药物科学家的必备读物。

《Letters In Drug Design & Discovery》(药物设计与发现快报)编辑部通讯方式为BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。